Grufity logo
Grufity logo

Latest Exome Asset Management LLC Stock Portfolio

$162Million | No. of Holdings #52

Exome Asset Management LLC Performance

2026 Q2+11.62%
YTD+16.50%
2025+51.08%

About Exome Asset Management LLC and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Exome Asset Management LLC reported an equity portfolio of $162.1 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Exome Asset Management LLC are GH, PRAX, TGTX. The fund has invested 6.2% of it's portfolio in GUARDANT HEALTH INC and 5.6% of portfolio in PRAXIS PRECISION MEDICINES I. <br><br> The fund managers got completely rid off ELEVANCE HEALTH INC FORMERLY (ANTX), APELLIS PHARMACEUTICALS INC (APLS) and AVALO THERAPEUTICS INC (AVTX) stocks. They significantly reduced their stock positions in RELAY THERAPEUTICS INC (RLAY), BRIDGEBIO PHARMA INC (BBIO) and ENLIVEN THERAPEUTICS INC. Exome Asset Management LLC opened new stock positions in TG THERAPEUTICS INC (TGTX), ABIVAX SA and UNIQURE NV (QURE). The fund showed a lot of confidence in some stocks as they added substantially to MAZE THERAPEUTICS INC.
Exome Asset Management LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$162Million
  as of Aug 14, 2026

Exome Asset Management LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Exome Asset Management LLC made a return of 11.62% in the last quarter. In trailing 12 months, it's portfolio return was 80.05%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
tg therapeutics inc9,060,430
abivax sa6,246,960
uniqure nv3,733,440
astrazeneca plc2,254,130
viking therapeutics inc1,867,060
ocular therapeutix inc1,783,190
equillium inc1,769,460
ascendis pharma a/s1,753,150
New stocks bought by Exome Asset Management LLC

Additions

Ticker% Inc.
maze therapeutics inc29.58
Additions to existing portfolio by Exome Asset Management LLC

Reductions

Ticker% Reduced
relay therapeutics inc-82.92
bridgebio pharma inc-72.8
enliven therapeutics inc-54.47
insmed inc-47.95
agios pharmaceuticals inc-43.63
cytokinetics inc-42.1
praxis precision medicines i-40.17
zenas biopharma inc-35.04
Exome Asset Management LLC reduced stake in above stock

Sold off

Ticker$ Sold
palisade bio inc-1,050,000
avalo therapeutics inc-2,378,960
4d molecular therapeutics in-1,215,550
nextcure inc-1,215,060
apellis pharmaceuticals inc-3,440,350
soleno therapeutics inc-2,064,810
lipocine inc new-486,279
elevance health inc formerly-4,296,690
Exome Asset Management LLC got rid off the above stocks

Sector Distribution

Exome Asset Management LLC has about 79.4% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare79.4
Others20.6

Market Cap. Distribution

Exome Asset Management LLC has about 23.9% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • LARGE-CAP
  • SMALL-CAP
  • MEGA-CAP
  • MICRO-CAP
Category%
MID-CAP43.8
UNALLOCATED20.6
LARGE-CAP17.4
SMALL-CAP9.4
MEGA-CAP6.5
MICRO-CAP2.2

Stocks belong to which Index?

About 51.5% of the stocks held by Exome Asset Management LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others48.5
RUSSELL 200042.5
S&P 5009
Top 5 Winners (%)%
LQDA
liquidia corporation
103.3 %
TXG
10x genomics inc
67.1 %
GH
guardant health inc
56.7 %
RLAY
relay therapeutics inc
51.5 %
ESTA
establishment labs hldgs inc
51.1 %
Top 5 Winners ($)$
GH
guardant health inc
4.3 M
TXG
10x genomics inc
2.2 M
enliven therapeutics inc
1.8 M
LQDA
liquidia corporation
1.8 M
LLY
eli lilly & co
1.7 M
Top 5 Losers (%)%
BSX
boston scientific corp
-32.0 %
INSM
insmed inc
-26.5 %
VSTM
verastem inc
-23.4 %
IMAB
novabridge biosciences
-20.7 %
CTMX
cytomx therapeutics inc.
-19.0 %
Top 5 Losers ($)$
INSM
insmed inc
-1.2 M
BSX
boston scientific corp
-1.0 M
VSTM
verastem inc
-0.8 M
CTMX
cytomx therapeutics inc.
-0.5 M
ISRG
intuitive surgical inc
-0.4 M

Exome Asset Management LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Exome Asset Management LLC

Exome Asset Management LLC has 52 stocks in it's portfolio. About 44.6% of the portfolio is in top 10 stocks. INSM proved to be the most loss making stock for the portfolio. GH was the most profitable stock for Exome Asset Management LLC last quarter.

$162.10MTotal Value
60.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Exome Asset Management LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ADAG
Adagene Inc

Adagene Inc

ADAG
Exome Asset Management LLC's holding in Adagene Inc over time
1.26%488,293
$2.05M
1.26%
decreased 33.73 percentreduced
DRUG
Bright Minds Biosciences Inc

Bright Minds Biosciences Inc

DRUG
Exome Asset Management LLC's holding in Bright Minds Biosciences Inc over time
0.44%10,110
$709.7K
0.44%
new position